BECK DOUGLAS 4
4 · AIT Therapeutics, Inc. · Filed Nov 6, 2018
Insider Transaction Report
Form 4
BECK DOUGLAS
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-02+85,000→ 85,000 totalExercise: $4.25Exp: 2022-11-01→ Common stock (85,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 25% of the shares after 12 months of continuous service, and the balance will vest in equal monthly installments over the next 36 months of continuous service.